Navigation Links
Clinical Update - Debio 025 in Hepatitis C
Date:4/28/2008

l Besseghir, CEO of Debiopharm S.A. "This unique mechanism of action is the first alternative treatment to classic HCV therapies."

Debio 025

Debio 025 is a synthetic first-in-class Cyp inhibitor, being tested in humans as a potential anti-HCV drug. Debio 025 binds strongly to Cyp, host cell proteins thought to confer a replication advantage to HCV. Its potent inhibitory activity on the HCV replication was shown in preclinical studies.

Previous results of a phase Ib study demonstrate that Debio 025 monotherapy for 15 days induced a strong anti-HCV effect (3.6 log10 reduction) in HIV-1/HCV co-infected patients. (Hepatology, Vol. 47, No 3, 2008, Flisiak et al. "The Cyclophilin Inhibitor Debio-025 Shows Potent Anti-Hepatitis C Effect in Patients Coinfected with Hepatitis C and Human Immunodeficiency Virus)."

About HCV

HCV is the most prevalent liver disease in the world and is considered by the World Health Organization as an epidemic. Because HCV can infect a patient for decades before being discovered, it is often called the "silent" epidemic. Studies suggest that over 200 million people worldwide are infected with HCV, an overall incidence of around 3.3% of the world's population. In the US alone, nearly 4 million people are or have been infected with HCV and of these, 2.7 million have an ongoing chronic infection, the majority being between 40 to 60 years old. A fourfold increase in the number of adults diagnosed with chronic HCV infection is projected from 1990 to 2015, since most persons with chronic HCV infection have yet to be diagnosed but are likely to come to medical attention in the next decade.

About Debiopharm Group

Debiopharm Group is a global biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug candidates. Debiopharm develops its products for global registration and maximum commercial potential for out-licensing to pharmaceutical partners for sales and marke
'/>"/>

SOURCE The Debiopharm Group
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Novagali Pharma Successfully Enrolls First Patient in U.S. Phase I Clinical Study with CORTIJECT(R) for Diabetic Macular Edema
2. ESBATechs Lead Antibody Fragment Enters Clinical Development for Ophthalmic Indications
3. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
4. More Clinical Data Required to Support European Approval of CAP Indication for TYGACIL
5. PTC Therapeutics Announces Initiation of Phase 2b Registration-Directed Clinical Trial of PTC124 in Duchenne/Becker Muscular Dystrophy
6. Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL)
7. Micromet Enrolls First Patient in a Phase 1 Clinical Trial with MT110, the First BiTE Antibody for Treatment of Solid Tumors
8. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
9. BrainCells Inc. Initiates Phase 2 Clinical Trial with BCI-540 for Depression with Anxiety
10. Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
11. AlphaVax Announces Initial Analysis of Data From CMV Phase 1 Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... BERKELEY, Calif. , July 29, 2015 ... member of the Daiichi Sankyo Group, announced today that ... published clinical trial results demonstrating that the investigational drug, ... regressions in most patients with tenosynovial giant cell tumor ... or tendon sheath. Following phase 1 dose-escalation, ...
(Date:7/29/2015)... Pa. , July 29, 2015 ... UNS), a developer, manufacturer and supplier of injectable ... the Imperium™ platform of instant patch pumps for ... disposable, multi-day wearable insulin pump that does not ... it is prefilled and pre-assembled like an insulin ...
(Date:7/29/2015)... , July 29, 2015 Varian Medical Systems, ... through one of its European subsidiaries, agreed to acquire ... of components and subsystems for X-ray imaging equipment manufacturers. Varian,s ... pay approximately €50 million in cash for Claymount. The ... Claymount is one of the world,s leading ...
Breaking Medicine Technology:Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 2Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 3Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 4Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 5Unilife Introduces World's First Instant Patch Pump for Insulin 2Unilife Introduces World's First Instant Patch Pump for Insulin 3Unilife Introduces World's First Instant Patch Pump for Insulin 4Varian Medical Systems Acquiring Claymount to Expand Imaging Components Portfolio 2Varian Medical Systems Acquiring Claymount to Expand Imaging Components Portfolio 3Varian Medical Systems Acquiring Claymount to Expand Imaging Components Portfolio 4
... Caliper Life Sciences, Inc. (Nasdaq: CALP ) ... DNA assay for its LabChip GX analytical platform, as ... GX assay is optimized for QC steps that assess ... libraries. The Sciclone NGS Workstation automates the most commonly ...
... Collagen Matrix, Inc., the leader in collagen- and ... its operations by the addition of a 28,000 sq. ... 07436. The company will be relocating the ... warehouse, and the administrative group to the newly renovated ...
Cached Medicine Technology:Caliper Life Sciences Expands Offering for Next Generation Sequencing Workflows 2Collagen Matrix, Inc. Expands Operations and Moves Corporate Headquarters to Oakland, New Jersey 2
(Date:7/29/2015)... ... July 29, 2015 , ... ... paper, Our Best Shot: Expanding Prevention through Vaccination in Older Adults, that provides ... offers recommendations on how industry, government, and health care experts can improve patient ...
(Date:7/29/2015)... ... ... Angelo’s FabriClean, an area rug cleaning company in South Surrey, has recently ... The company will now reverse the damage caused by water on carpets for homes ... rain leaking through an accidently left open window or a broken underground pipeline can ...
(Date:7/29/2015)... ... July 29, 2015 , ... Ticket Down is a reliable source of authentic ... USA . , The international soccer schedule of matches played on American soil ... September 8th, one of the world’s greatest teams, Brazil, will travel to North America ...
(Date:7/29/2015)... FL (PRWEB) , ... July 29, 2015 , ... According ... fruit flies revealed a gene which is directly responsible for stimulating and perpetuating alcohol ... published in the journal entitled Proceedings of the National academy of Sciences, and has ...
(Date:7/29/2015)... ... July 29, 2015 , ... CrossFit 269, offering a ... to Kalamazoo Strength & Conditioning. , The name change coincides with the release ... our training center over the past three years,” according to Jack Kelly, the ...
Breaking Medicine News(10 mins):Health News:Vaccination Rates in Older Adults Fall Short of Targets 2Health News:Vaccination Rates in Older Adults Fall Short of Targets 3Health News:Angelo’s FabriClean Now Offers Water Damage Restoration For Residential and Commercial Accounts 2Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 2Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 3Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 2Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 2Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 4
... HealthDay Reporter , WEDNESDAY, Jan. 4 (HealthDay News) ... limited effectiveness in thwarting one type of the sexually transmitted ... spreading, a new study shows. , , A group of ... than 8,300 women aged 18 to 30 who tested negative ...
... Jan. 5 (HealthDay News) -- More than half of U.S. ... 2009-10 outbreak of H1N1 swine flu, a new study says. ... exposure to infectious diseases. The steady stream of new arrivals ... close confinement makes it easy for diseases to spread, researchers ...
... Fla. -- Fibroblasts, cells that play a role in ... in melanoma tumor growth. Fibroblasts also contribute to melanoma ... when a tumor,s metabolism is enhanced following a patient ... Moffitt Cancer Center in Tampa, Fla. Alexander ...
... , WEDNESDAY, Jan. 4 (HealthDay News) -- ... humans, the U.S. Food and Drug Administration on Wednesday ... and poultry. Widespread use of antibiotics in food-producing ... antibiotic-resistant strains of bacteria, experts say. The new ...
... , THURSDAY, Jan. 5 (HealthDay News) -- Toddlers who ... disorders later in life, a new study indicates. Researchers ... found that depriving them of a single daily nap resulted ... reduced problem-solving abilities. "Many young children today are not ...
... Hyperglycemia, or having high glucose levels in the ... care problem in hospitalized patients. Today, The Endocrine ... recommendations for practical and safe glycemic targets and ... glycemic goals for hospitalized patients in a non-critical ...
Cached Medicine News:Health News:Potential Herpes Vaccine Disappoints Researchers 2Health News:Potential Herpes Vaccine Disappoints Researchers 3Health News:Many Jails Got No Flu Shots During H1N1 Outbreak: CDC 2Health News:Fibroblasts contribute to melanoma tumor growth, say Moffitt Cancer Center researchers 2Health News:FDA Curbs Use of Certain Antibiotics in Livestock, Poultry 2Health News:FDA Curbs Use of Certain Antibiotics in Livestock, Poultry 3Health News:Missed Naps Could Put Toddlers at Risk for Mood Disorders 2Health News:Experts suggest all hospitalized patients have blood glucose levels tested 2Health News:Experts suggest all hospitalized patients have blood glucose levels tested 3
This instrument measures intraocular pressure without,contacting. Alignment is performed semi-automatically....
... VK-2 is a professional digital imaging system ... features you need to acquire, analyze, and ... the tools you use the most are,available ... results quickly and easily. This high-resolution system ...
The convenience of safe and precise Patient Controlled Analgesia in a flexible system designed with advanced technology. This is progressive, innovative, and effective pain management in a sophistica...
... Ipump Pain Management System answers the ... with one-on-one flexibility. From programming to ... customizable pain management right where you ... is designed to help each patient ...
Medicine Products: